SCHEMBL19156830

SCHEMBL19156830

CCCCCC(C)OC(=O)CCN1CCNCC1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 5/20 0.45
▸ CNR1 P21554 1/20 0.45
▸ CNR2 P34972 1/20 0.45
▸ HRH2 P25021 1/20 0.44
▸ HRH1 P35367 1/20 0.44
▸ SIGMAR1 Q99720 2/20 0.41
▸ LMNA P02545 2/20 0.40
▸ GNAI3 P08754 3/20 0.39
▸ GNAO1 P09471 3/20 0.39
▸ GNAI1 P63096 3/20 0.39
▸ EPHX2 P34913 1/20 0.38
▸ MAPT P10636 2/20 0.36
▸ CHRM5 P08912 1/20 0.36
▸ CHRM3 P20309 1/20 0.36
▸ SIRT2 Q8IXJ6 1/20 0.36
▸ SIRT1 Q96EB6 1/20 0.36
▸ SIRT3 Q9NTG7 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6603994 0.79 CHRM5 (0.44) HRH2HRH1LMNAMAPTCHRM5
SCHEMBL9986402 0.76 FAAH (0.65) FAAHCNR1CNR2LMNAEPHX2
SCHEMBL27879559 0.76 LMNA (0.66) FAAHCNR1CNR2LMNAEPHX2
SCHEMBL9958885 0.76 LMNA (0.66) FAAHCNR1CNR2LMNAEPHX2
SCHEMBL22534407 0.76 FAAH (0.60) FAAHCNR1CNR2LMNAEPHX2
SCHEMBL27918401 0.76 FAAH (0.65) FAAHCNR1CNR2LMNAEPHX2
SCHEMBL8362073 0.76 FAAH (0.60) FAAHCNR1CNR2LMNAEPHX2
SCHEMBL6606038 0.76 HRH2 (0.54) HRH2HRH1SIGMAR1LMNAGNAI3
Hydrochloric Acid SCHEMBL31722504 0.74 HRH2 (0.53) HRH2HRH1SIGMAR1LMNAGNAI3
SCHEMBL2597710 0.74 CHRM5 (0.40) HRH2HRH1SIGMAR1CHRM5CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3196200-B1 2-AMINOTHIAZOLE DERIVATIVES OR SALT THEREOF AS MUSCARINIC M3 LIGANDS FOR THE TREATMENT OF BLADDER DISEASES ASTELLAS PHARMA INC (JP) 2019-05-08 — — EP disclosed
EP-3196200-A1 2-AMINOTHIAZOLE DERIVATIVE OR SALT THEREOF Astellas Pharma Inc. (JP) 2017-07-26 — — EP disclosed
Send feedback